EVIDENCE-BASED CHOICE OF ACE INHIBITORS

EVIDENCE-BASED CHOICE OF ACE INHIBITORS

Angiotensin-converting enzyme (ACE) inhibitors are currently one of the most frequently used groups of cardiovascular medications. In addition to wellknown indications, such as arterial hypertension (AH), chronic heart failure (CHF), and Type 2 diabetes mellitus (DM-2), some ACE inhibitors could be...

Full description

Bibliographic Details
Main Authors: G. E. Gendlin, O. A. Miller, A. V. Melekhov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2012-08-01
Series:Российский кардиологический журнал
Subjects:
new indications for ace inhibitors
endothelial dysfunction
vasoprotection
perindopril a
primary prevention of coronary heart disease
secondary prevention of stroke
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1256
id doaj-0dd19e7bcfe549c78a334127501cbb28
record_format Article
spelling doaj-0dd19e7bcfe549c78a334127501cbb282021-07-28T14:02:17Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202012-08-010487921055EVIDENCE-BASED CHOICE OF ACE INHIBITORSG. E. Gendlin0O. A. Miller1A. V. Melekhov2Russian Medical University, MoscowRussian Medical University, MoscowRussian Medical University, MoscowAngiotensin-converting enzyme (ACE) inhibitors are currently one of the most frequently used groups of cardiovascular medications. In addition to wellknown indications, such as arterial hypertension (AH), chronic heart failure (CHF), and Type 2 diabetes mellitus (DM-2), some ACE inhibitors could be used in other clinical situations. The medications with additional vascular activity (for example, perindopril A) have certain benefits, compared to other ACE inhibitors.https://russjcardiol.elpub.ru/jour/article/view/1256new indications for ace inhibitorsendothelial dysfunctionvasoprotectionperindopril aprimary prevention of coronary heart diseasesecondary prevention of stroke
collection DOAJ
language Russian
format Article
sources DOAJ
author G. E. Gendlin
O. A. Miller
A. V. Melekhov
spellingShingle G. E. Gendlin
O. A. Miller
A. V. Melekhov
EVIDENCE-BASED CHOICE OF ACE INHIBITORS
Российский кардиологический журнал
new indications for ace inhibitors
endothelial dysfunction
vasoprotection
perindopril a
primary prevention of coronary heart disease
secondary prevention of stroke
author_facet G. E. Gendlin
O. A. Miller
A. V. Melekhov
author_sort G. E. Gendlin
title EVIDENCE-BASED CHOICE OF ACE INHIBITORS
title_short EVIDENCE-BASED CHOICE OF ACE INHIBITORS
title_full EVIDENCE-BASED CHOICE OF ACE INHIBITORS
title_fullStr EVIDENCE-BASED CHOICE OF ACE INHIBITORS
title_full_unstemmed EVIDENCE-BASED CHOICE OF ACE INHIBITORS
title_sort evidence-based choice of ace inhibitors
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2012-08-01
description Angiotensin-converting enzyme (ACE) inhibitors are currently one of the most frequently used groups of cardiovascular medications. In addition to wellknown indications, such as arterial hypertension (AH), chronic heart failure (CHF), and Type 2 diabetes mellitus (DM-2), some ACE inhibitors could be used in other clinical situations. The medications with additional vascular activity (for example, perindopril A) have certain benefits, compared to other ACE inhibitors.
topic new indications for ace inhibitors
endothelial dysfunction
vasoprotection
perindopril a
primary prevention of coronary heart disease
secondary prevention of stroke
url https://russjcardiol.elpub.ru/jour/article/view/1256
work_keys_str_mv AT gegendlin evidencebasedchoiceofaceinhibitors
AT oamiller evidencebasedchoiceofaceinhibitors
AT avmelekhov evidencebasedchoiceofaceinhibitors
_version_ 1721269399184211968

Similar Items